论文信息 - Novel function of RANKL: eNOS activator

Novel function of RANKL: eNOS activator

[Comment on Min et al, page 1495][1]In this issue of Blood , Min and colleagues report that RANKL is a potent activator of endothelial nitric oxide synthase (eNOS) and induces vascular hyperpermeability and angiogenesis in an eNOS-NO–dependent manner. Receptor activator of nuclear factor (NF

R. Jain | D. Fukumura

[1] R. Jain,et al. The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[2] In Koo Hwang,et al. TNF-Related Activation-Induced Cytokine Enhances Leukocyte Adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF Receptor-Associated Factor and Protein Kinase C-Dependent NF-κB Activation in Endothelial Cells1 , 2005, The Journal of Immunology.

[3] L. Hofbauer,et al. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. , 2004, JAMA.

[4] Y. M. Lee,et al. TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.